BioPharma
Overcoming Challenges In Biopharma Novel Drug Manufacturing
The biopharmaceutical sector is undergoing a significant transformation in treating complex diseases, especially in oncology, driven by innovative drug approaches. This shift entails personalized therapies,...
BioPharma
Enhanced Biopharmaceutical Release: Autonomous PAT Power
Speeding up biomanufacturing using automated Process Analytical Technology (PAT) systems
A2P2 and Micro Sequential Injection (SI), two cutting-edge process analysers, have been cited as autonomous PAT...
BioPharma
Overcoming Treatment Challenges With Cell And Gene Therapies
Gene and cell therapies have the potential to revolutionize healthcare by reprogramming the immune system to treat diseases that are difficult to address with traditional...
BioPharma
Boosting Innovation And Value In UK Biopharma And Medtech
New recommendations from Imperial College London aim to boost competitiveness in the UK's biopharma and Medtech sectors. It assesses the value-added per capita in these...
BioPharma
Cell And Gene Therapy CDMO Services Market Is On...
The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which was valued at USD 5,193.7 million in 2022, is expected...
Articles
What’s driving the growth of the biopharma sector across...
Standfirst: The healthcare industry, particularly the life-science and biopharma sectors, across ASEAN is seeing a shift away from a reliance on overseas expertise and imported...
BioPharma
Lack of Experience Hinders CDMOs In Cell And Gene...
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene therapy...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.